BridgeBio Pharma Inc (BBIO)

28.27 -0.12 (-0.42%) USD  |  NASDAQ  |  Dec 27, 10:04
More

BridgeBio Pharma Cash and Short Term Investments (Annual): 434.88M for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Pfizer Inc 12.69B
Alnylam Pharmaceuticals Inc 2.439B
Cassava Sciences Inc 121.14M
Regeneron Pharmaceuticals Inc 10.84B
Vertex Pharmaceuticals Inc 11.22B